Breaking news: $28M raised in series C funding Read News

Smart AI for early breast cancer detection and diagnosis

We focus on improving breast cancer survival rates by detecting cancers earlier and making treatment more effective and less invasive.

CE marked and FDA cleared 

READ OUR RESPONSE TO COVID-19 AND HOW TRANSPARA CAN HELP

An introduction to Screenpoint

Here’s a short introduction to what we do

Why Transpara?

Trusted in more than 25 countries

Trusted in more than 25 countries

FDA cleared and CE marked for 2D and 3D mammography

FDA cleared and CE marked for 2D and 3D mammography

The most independent peer reviewed publications in breast AI

The most independent peer reviewed publications in breast AI

Proven multivendor compatibility

Proven multivendor compatibility

Integrated with most workstations

Integrated with most workstations

Experience the benefit of our continuously evolving deep learning algorithm

Experience the benefit of our continuously evolving deep learning algorithm

Peer Reviewed Publications

Accuracy.
Workload Reduction.
Risk.

"The ScreenPoint team is a smart and innovative group. Transpara should have a beneficial impact on any breast imaging practice."

Dr Roger Yang

MD, FACR, University Radiology Group

“I could see the potential benefits of using AI for my practice and for my patients and it was a real success. With each release, the Transpara algorithms are continually getting better and better. I use it all the time and won’t read another 3D mammogram without it!”

Dr Daniel Gurell

Vice President and Associate Medical Director at University Diagnostic Medical Imaging P.C.USA

“Transpara may allow discriminating studies, which require more attention and selection of those, which may be handled with single reading for example. It may thus contribute significantly to both risk adapted screening and optimum assignment of resources."

Professor Sylvia H Heywang-Köbrunner

Radiologist, Head of the Referenzzentrum Mammographie Munich, Germany

"We are at the forefront of one of the first prospective studies with Transpara. As we will implement Transpara in a real-life screening setting in Ostergotland County, we aim to improve the quality of the breast cancer screening program while at the same time safely reduce the workload of breast radiologists."

Håkan Gustafsson

Deputy Director CMIV, AI Coordinator at Region Östergötland

The Transpara Process

The Transpara Process
Client scan

Client scan

Client undergoes mammogram

Analyze scan

Analyze scan

Transpara analyses mammogram scan

Reading with Transpara

Reading with Transpara

Radiologist reads with support from Transpara, increasing confidence in decision

Result

Make more accurate and consistent decision

News

Announcement


ScreenPoint Medical showcases world leading Transpara® powered by FusionAI at RSNA

It follows a year of major achievements for the organisation with Transpara which is now installed in health care facilities

Read more

Announcement


Aidoc and ScreenPoint Medical Announce Partnership to Provide Complete AI Solution for Breast Imaging

Aidoc, the leading provider of AI for medical imaging, and ScreenPoint Medical, leader of deep learning AI for 2D and

Read more

Announcement


Transpara® AI Reads Mammograms From Over Two Million Women

The Transpara deep learning artificial intelligence (AI) software, which helps radiologists identify breast cancers faster and earlier, has now been

Read more

Publication


New peer-reviewed study in Radiology; the first with Norwegian radiologists using AI to help with reading 3D mammography.

Another publication to add to the strong global evidence base supporting Transpara. This time in the Radiology journal, showing the

Read more

Announcement


ScreenPoint Medical Adds Global Experience to its Board

We are very excited to have Dr Rachel Brem and Allyson White join our ScreenPoint Medical supervisory board. We are

Read more

Announcement


We are hiring!

Here’s our HR Manager, Marieke on why you should consider joining our dynamic team today to help make a difference

Read more